Skip to main content

Table 4 Systemic arterial gas and metabolic variables

From: Adenosine, lidocaine and Mg2+improves cardiac and pulmonary function, induces reversible hypotension and exerts anti-inflammatory effects in an endotoxemic porcine model

 

Baseline

30 minutes

60 minutes

90 minutes

120 minutes

150 minutes

180 minutes

210 minutes

240 minutes

270 minutes

300 minutes

Arterial pH

           

 Control

7.48 (7.47 to 7.49)

7.48 (7.47 to 7.50)

7.44 (7.43 to 7.46)

7.44 (7.42 to 7.45)

7.44 (7.42 to 7.45)

7.42 (7.40 to 7.43)

7.41 (7.40 to 7.43)

7.41 (7.39 to 7.42)

7.41 (7.40 to 7.43)

7.41 (7.40 to 7.42)

7.41 (7.39 to 7.42)

 ALM

7.48 (7.47 to 7.50)

7.48 (7.46 to 7.49)

7.45 (7.44 to 7.46)

7.44 (7.42 to 7.45)

7.41 (7.40 to 7.43)

7.41 (7.40 to 7.43)

7.40 (7.39 to 7.42)

7.40 (7.39 to 7.42)

7.40 (7.38 to 7.42)

7.40 (7.38 to 7.41)

7.40 (7.39 to 7.41)

PaO2 (mmHg)

           

 Control

182 (161 to 205)

118 (105 to 135)

154 (136 to 173)

157 (139 to 177)

144 (127 to 162)

117 (103 to 132)

111 (98 to 125)

110 (98 to 124)

127 (112 to 143)

126 (111 to 142)

115 (102 to 130)

 ALMa

184 (163 to 207)

173 (154 to 196)

174 (154 to 197)

169 (150 to 191)

168 (148 to 189)

170 (150 to 191)

167 (148 to 188)

163 (144 to 184)

150 (133 to 169)

151 (134 to 171)

147b (130 to 166)

PaCO2 (mmHg)

           

 Control

43 (42 to 44)

41 (40 to 42)

44 (42 to 45)

44 (42 to 45)

44 (43 to 45)

44 (43 to 46)

45 (44 to 46)

45 (44 to 46)

44 (43 to 45)

43 (42 to 44)

44 (43 to 45)

 ALM

43 (41 to 44)

41 (40 to 42)

42 (41 to 44)

42 (41 to 44)

44 (43 to 35)

44 (42 to 45)

44 (43 to 45)

43 (42 to 44)

44 (42 to 45)

45 (44 to 46)

45 (44 to 46)

ETCO2 (mmHg)

           

 Control

43 (42 to 45)

42 (41 to 43)

45 (44 to 47)

45 (44 to 46)

44 (43 to 45)

43 (42 to 45)

42 (40 to 43)

41 (39 to 42)

40 v(39 to 41)

40 (39 to 41)

40 (39 to 41)

 ALMc

45 (44 to 46)

42 (41 to 44)

45 (44 to 46)

45 (43 to 46)

45 (44 to 47)

44 (43 to 46)

45 (44 to 46)

44 (42 to 45)

44 (43 to 45)

44 (43 to 45)

44b (42 to 45)

HCO3 (mmol/l)

           

 Control

31.4 (30.6 to 32.2)

30.5 (29.7 to 31.3)

29.1 (28.3 to 29.9)

28.7 (27.9 to 29.4)

28.7 (27.9 to 29.4)

27.8 (27.1 to 28.6)

27.6 (26.8 to 28.4)

27.1 (26.3 to 27.9)

26.9 (26.1 to 27.7)

26.6 (25.8 to 27.4)

26.8 (26.0 to 27.6)

 ALM

31.4 (30.7 to 32.2)

30.3 (29.5 to 31.0)

29.0 (28.2 to 29.8)

28.1 (27.3 to 28.8)

27.4 (26.6 to 28.1)

27.0 (26.2 to 27.7)

26.6 (25.8 to 27.4)

26.5 (25.7 to 27.3)

26.1 (25.3 to 26.9)

26.4 (25.6 to 27.1)

26.6 (25.8 to 27.4)

Lactate (mmol/l)

           

 Control

0.8 (0.6 to 0.9)

0.8 (0.6 to 1.0)

1.1 (0.9 to 1.2)

1.1 (0.9 to 1.2)

1.2 (1.0 to 1.3)

1.2 (1.1 to 1.4)

1.3 (1.1 to 1.4)

1.3 (1.2 to 1.5)

1.3 (1.2 to 1.5)

1.2 (1.1 to 1.4)

1.1 (0.9 to 1.2)

 ALMc

0.7 (0.6 to 0.9)

1.0 (0.8 to 1.1)

1.2 (1.0 to 1.3)

1.2 (1.0 to 1.4)

1.2 (1.0 to 1.4)

1.2 (1.0 to 1.3)

1.2 (1.0 to 1.3)

1.1 (1.0 to 1.3)

1.1 (0.9 to 1.3)

1.0 (0.8 to 1.1)

0.8b (0.7 to 1.0)

  1. Data presented as median (95% confidence interval), except for pH, lactate, and ETCO2 which are presented as mean (95% confidence interval). ALM, adenosine, lidocaine and magnesium; ETCO2, end-tidal carbon dioxide; PaCO2, arterial partial pressure of carbon dioxide; PaO2, arterial partial pressure of oxygen. aSignificantly different mean/median level between groups. bSignificant difference at the end of the study. cSignificantly different change over time between groups.